SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 76,900
+2,000 (2.67%)
Oct 23, 2026, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.02 trillion as of October 23, 2026. It is the 3,838th most valuable company in the world and the 90th biggest in South Korea. Its market cap has decreased by 28.93% in one year.
Market Cap
6.02T
Enterprise Value
5.69T
Revenue
861.34B
Global Rank
Country Rank
#90 South Korea
PE Ratio
15.02
ChartMarket Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.02T, a decrease of -39.45%. That is a compound annual growth rate of -7.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 6.02T | -38.28% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 16.22T |
| Samsung Epis Holdings | 8.21T |
| HLB Co., Ltd. | 5.50T |
| SK bioscience | 2.74T |
| LigaChem Biosciences | 2.60T |
| ABL Bio | 2.53T |
| Peptron | 2.46T |
| Voronoi | 2.43T |